EUVIMEDEUVIMED entdecken
Crossref

The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target

Claudio Graziani, Anna Barile, Lorenzo Antonelli, Annarita Fiorillo, Andrea Ilari, Fabrizio Vetica, Martino Luigi di Salvo, Alessandro Paiardini iD, Angela Tramonti iD, Roberto Contestabile iD

The FEBS Journal · 2024

DOI: 10.1111/febs.17274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2024. Verfasst von Claudio Graziani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy. Hauptthemen laut MEDLINE: Pyridoxaminephosphate Oxidase, Vitamin B 6, Pyridoxal Phosphate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Istituto Pasteur - Fondazione Cenci Bolognetti, European Union - NextGenerationEU, Sapienza Università di Roma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyridoxal 5′‐phosphate (PLP), the catalytically active form of vitamin B 6 , acts as a cofactor in many metabolic processes. In humans, PLP is produced in the reactions catalysed by pyridox(am)ine 5′‐phosphate oxidase (PNPO) and pyridoxal kinase (PDXK). Both PNPO and PDXK are involved in cancer progression of many tumours. The silencing of PNPO and PDXK encoding genes determines a strong reduction in tumour size and neoplastic cell invasiveness in models of acute myeloid leukaemia (in the case of PDXK) and ovarian and breast cancer (in the case of PNPO). In the present work, we demonstrate that pyridoxilidenerhodanine 5′‐phosphate (PLP‐R), a PLP analogue that has been tested by other authors on malignant cell lines reporting a reduction in proliferation, inhibits PNPO in vitro following a mixed competitive and allosteric mechanism. We also show that the unphosphorylated precursor of this inhibitor (PL‐R), which has more favourable pharmacokinetic properties according to our predictions, is phosphorylated by PDXK and therefore transformed into PLP‐R. On this ground, we propose the prototype of a novel prodrug‐drug system as a useful starting point for the development of new, potential, antineoplastic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pyridoxaminephosphate OxidaseVitamin B 6Pyridoxal PhosphateHumansEnzyme InhibitorsCell ProliferationCell Line, TumorPyridoxal KinaseAntineoplastic Agents

Stichwörter der Autor:innen

PNPOchemotherapy agentsenzyme inhibitionprodrug‐drug systemvitamin B6 salvage pathway

Substanzen

Pyridoxaminephosphate OxidaseVitamin B 6Pyridoxal PhosphateEnzyme InhibitorsPyridoxal KinaseAntineoplastic Agents

Autor:innen und Institutionen

  • Dipartimento di Scienze Biochimiche "A. Rossi Fanelli", Sapienza Università di Roma, Italy.
  • Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, Rome, Italy.
  • Dipartimento di Chimica, Sapienza Università di Roma, Italy.
  • Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy.

ORCID-Profile: Alessandro Paiardini, Angela Tramonti, Roberto Contestabile

Förderung

  • Istituto Pasteur - Fondazione Cenci Bolognetti
  • European Union - NextGenerationEU
  • Sapienza Università di Roma
  • Consiglio Nazionale delle Ricerche
  • Istituto Pasteur-Fondazione Cenci Bolognetti

Zitieren

APA

Graziani, C., Barile, A., Antonelli, L., Fiorillo, A., Ilari, A., Vetica, F., di Salvo, M. L., Paiardini, A., Tramonti, A., & Contestabile, R. (2024). The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target. The FEBS Journal. https://doi.org/10.1111/febs.17274

Vancouver

Graziani C, Barile A, Antonelli L, Fiorillo A, Ilari A, Vetica F, et al. The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target. The FEBS Journal. 2024. doi:10.1111/febs.17274

BibTeX
@article{Graziani2024,
  author = {Graziani, Claudio and Barile, Anna and Antonelli, Lorenzo and Fiorillo, Annarita and Ilari, Andrea and Vetica, Fabrizio and di Salvo, Martino Luigi and Paiardini, Alessandro and Tramonti, Angela and Contestabile, Roberto},
  title = {The Z isomer of pyridoxilidenerhodanine 5′‐phosphate is an efficient inhibitor of human pyridoxine 5′‐phosphate oxidase, a crucial enzyme in vitamin B 6 salvage pathway and a potential chemotherapeutic target},
  journal = {The FEBS Journal},
  year = {2024},
  doi = {10.1111/febs.17274}
}
Kostenlos starten →